Investor Relations

 

PT Siloam International Hospitals Tbk (the “Company”, Ticker: SILO) operates the largest private hospital network in Indonesia.

Starting in 1996 as PT Sentralindo Wirasta, the Company now manages 37 (thirty-seven) operating hospitals, comprising 8 (eight) hospitals in Greater Jakarta and 29 (twenty-nine) hospitals located across Java, Sumatra, Kalimantan, Sulawesi, Bali and Nusa Tenggara. From the 37 hospitals in operation, 26 (twenty-six) hospitals are already serving BPJS Kesehatan (National Insurance Program) patients, with more to follow in near future.

The Company operates 23 (twenty-three) clinics equipped with GPs, nurses, and dentists to provide primary healthcare throughout the nation. The Company listed its shares at the Indonesia Stock Exchange in September 2013, as PT Siloam International Hospitals Tbk with code SILO. 

Siloam Hospitals has expanded its Centers of Excellence with the Parkinson’s & Movement Disorder Center and Siloam Hospital Kebon Jeruk. Sustainable investment in both technology and medical staff supports a strategic goal to offer a comprehensive range of specialist and general medical services including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic and emergency services. By the end of 2019, Siloam Hospital have 16 (sixteen) Cath Labs, 16 (sixteen) MRI, 37 (thirty-seven) CT-Scan, 1 (one) Gamma Knife, 3 (three) Linear Accelerators, and 1 (one) Cyclotron within its integrated network.

Siloam Hospitals Lippo Village, Siloam Hospitals Kebon Jeruk and Siloam Hospitals Denpasar are accredited by the Joint Commission International (JCI), while BIMC Nusa Dua accredited by the Australian Council on Healthcare Standards (ACHS). The Company will look forward for further certifications of more hospitals in the future.

As of year-end 2019, Siloam Hospitals had a bed capacity of 7,628 with 2,904 doctors, of which about 2,253 are specialists, as well as 4,989 nurses, allied health technicians and support staff providing care during 2019 for 2.75 million patients.